Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence

被引:130
|
作者
Maurer, M. [1 ]
Metz, M. [1 ]
Bindslev-Jensen, C. [2 ,18 ]
Bousquet, J. [3 ,4 ,5 ]
Canonica, G. W. [6 ]
Church, M. K. [1 ]
Godse, K. V. [7 ]
Grattan, C. E. [8 ]
Hide, M. [9 ]
Kocaturk, E. [10 ]
Magerl, M. [1 ]
Makris, M. [11 ]
Meshkova, R. [12 ]
Saini, S. S. [13 ]
Sussman, G. [14 ]
Toubi, E. [15 ]
Zhao, Z. [16 ]
Zuberbier, T. [1 ]
Gimenez-Arnau, A. [17 ]
机构
[1] Charite, Dept Dermatol & Allergy, Allergie Ctr Charite, Charite Pl 1, D-10117 Berlin, Germany
[2] Odense Univ Hosp, Dept Dermatol, Odense Res Ctr Anaphylaxis, Odense, Denmark
[3] Univ Hosp, Montpellier, France
[4] INSERM, VIMA Ageing & Chron Dis, Epidemiol & Publ Hlth Approaches, Paris, France
[5] Univ Versailles St Quentin En Yvelines, UVSQ, UMR S 1168, St Quentin En Yvelines, France
[6] Univ Genoa, IRCCS AOU San Martino IST, Genoa, Italy
[7] DY Patil Sch Med, Dept Dermatol, Nerul, Navi Mumbai, India
[8] Norfolk & Norwich Univ Hosp, Norwich, Norfolk, England
[9] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dermatol, Hiroshima, Japan
[10] Okmeydani Training & Res Hosp, Dept Dermatol, Istanbul, Turkey
[11] Attikon Univ Hosp, Dept Dermatol & Venereol 2, Athens, Greece
[12] Smolensk State Med Univ, Dept Clin Immunol & Allergy, Smolensk, Russia
[13] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[14] Univ Toronto, Div Allergy & Immunol, Toronto, ON, Canada
[15] Technion Israel Inst Technol, Allergy & Clin Immunol, Bnai Zion Med Ctr, Haifa, Israel
[16] Peking Univ, Hosp 1, Dept Dermatol & Venereol, Beijing, Peoples R China
[17] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, IMIM, Barcelona, Spain
[18] Odense Univ Hosp, Allergy Ctr, Odense Res Ctr Anaphylaxis, Odense, Denmark
关键词
angioedema; center; excellence; management; urticaria; QUALITY-OF-LIFE; VALIDATION; OMALIZUMAB; INSTRUMENT; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; NETWORK;
D O I
10.1111/all.12901
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BackgroundGA(2)LEN, the Global Allergy and Asthma European Network, has recently launched a program for the development, interaction, and accreditation of centers of reference and excellence in special areas of allergy embedded in its overall quality management of allergy centers of excellence. The first area chosen is urticaria. Urticaria is a common and debilitating condition and can be a challenge for both patients and treating physicians, especially when chronic. Centers of reference and excellence in urticaria (UCAREs) can help to improve the management of hard-to-treat conditions such as urticaria. AimsHere, we describe the aims, the requirements and deliverables, the application process, and the audit and accreditation protocol for GA(2)LEN UCAREs. ResultsThe main aims of GA(2)LEN UCAREs are to provide excellence in urticaria management, to increase the knowledge of urticaria by research and education, and to promote the awareness of urticaria by advocacy activities. To become a certified GA(2)LEN UCARE, urticaria centers have to apply and fulfill 32 requirements, defined by specific deliverables that are assessed during an audit visit. Discussion and ConclusionThe GA(2)LEN UCARE program will result in a strong network of urticaria specialists, promote urticaria research, and harmonize and improve urticaria management globally.
引用
收藏
页码:1210 / 1218
页数:9
相关论文
共 50 条
  • [31] GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management
    Zuberbier, Torsten
    Muraro, Antonella
    Nurmatov, Ulugbek
    Arasi, Stefania
    Stevanovic, Katarina
    Anagnostou, Aikaterini
    Bonaguro, Roberta
    Chinthrajah, Sharon
    Lack, Gideon
    Fiocchi, Alessandro
    Le, Thuy-My
    Turner, Paul
    Lozano, Montserrat Alvaro
    Angier, Elizabeth
    Barni, Simona
    Begin, Phillippe
    Ballmer-Weber, Barbara
    Cardona, Victoria
    Bindslev-Jensen, Carsten
    Cianferoni, Antonella
    de Jong, Nicolette
    de Silva, Debra
    Deschildre, Antoine
    Galvin, Audrey Dunn
    Ebisawa, Motohiro
    Fleischer, David M.
    Gerdts, Jennifer
    Giovannini, Mattia
    Gradman, Josefine
    Halken, Susanne
    Arshad, Syed Hasan
    Khaleva, Ekaterina
    Lau, Susanne
    Loh, Richard
    Makela, Mika J.
    Marchisotto, Mary Jane
    Morandini, Laura
    Mortz, Charlotte G.
    Nilsson, Caroline
    Nowak-Wegrzyn, Anna
    Podesta, Marcia
    Poulsen, Lars K.
    Roberts, Graham
    del Rio, Pablo Rodriguez
    Sampson, Hugh A.
    Sanchez, Angel
    Schnadt, Sabine
    Smith, Peter K.
    Szajewska, Hania
    Mitrevska, Natasa Teovska
    CLINICAL AND TRANSLATIONAL ALLERGY, 2024, 14 (11)
  • [32] Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA2LEN - ARIA Position Paper
    Bousquet, J.
    Anto, J. M.
    Demoly, P.
    Schuenemann, H. J.
    Togias, A.
    Akdis, M.
    Auffray, C.
    Bachert, C.
    Bieber, T.
    Bousquet, P. J.
    Carlsen, K. H.
    Casale, T. B.
    Cruz, A. A.
    Keil, T.
    Carlsen, K. C. Lodrup
    Maurer, M.
    Ohta, K.
    Papadopoulos, N. G.
    Rodriguez, M. Roman
    Samolinski, B.
    Agache, I.
    Andrianarisoa, A.
    Ang, C. S.
    Annesi-Maesano, I.
    Ballester, F.
    Baena-Cagnani, C. E.
    Basagana, X.
    Bateman, E. D.
    Bel, E. H.
    Bedbrook, A.
    Beghe, B.
    Beji, M.
    Ben Kheder, A.
    Benet, M.
    Bennoor, K. S.
    Bergmann, K. C.
    Berrissoul, F.
    Jensen, C. Bindslev
    Bleecker, E. R.
    Bonini, S.
    Boner, A. L.
    Boulet, L. P.
    Brightling, C. E.
    Brozek, J. L.
    Bush, A.
    Busse, W. W.
    Camargos, P. A. M.
    Canonica, G. W.
    Carr, W.
    Cesario, A.
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2012, 158 (03) : 216 - 231
  • [33] Sensitization to inhalative allergens in Europe - summary of the GA2LEN skin prick test studies
    Burbach, G. J.
    Heinzerling, L. M.
    Zuberbier, T.
    ALLERGOLOGIE, 2012, 35 (03) : 103 - 109
  • [34] GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'
    Bousquet, J.
    Burney, P. G.
    Zuberbier, T.
    v. Cauwenberge, P.
    Akdis, C. A.
    Bindslev-Jensen, C.
    Bonini, S.
    Fokkens, W. J.
    Kauffmann, F.
    Kowalski, M. L.
    Lodrup-Carlsen, K.
    Mullol, J.
    Nizankowska-Mogilnicka, E.
    Papadopoulos, N.
    Toskala, E.
    Wickman, M.
    Anto, J.
    Auvergne, N.
    Bachert, C.
    Bousquet, P. J.
    Brunekreef, B.
    Canonica, G. W.
    Carlsen, K. H.
    Gjomarkaj, M.
    Haahtela, T.
    Howarth, P.
    Lenzen, G.
    Lotvall, J.
    Radon, K.
    Ring, J.
    Salapatas, M.
    Schuenemann, H. J.
    Szczecklik, A.
    Todo-Bom, A.
    Valovirta, E.
    von Mutius, E.
    Zock, J. P.
    ALLERGY, 2009, 64 (07) : 969 - 977
  • [35] Risk Factors for the Absence of Diagnosis of Asthma Despite Disease Symptoms: Results from the Swedish GA2LEN Study
    Kisiel, Marta A.
    Jacobsson, Martin
    Jarhult, Susann
    Ekerljung, Linda
    Alving, Kjell
    Middelveld, Roelinde
    Franklin, Karl
    Janson, Christer
    JOURNAL OF ASTHMA AND ALLERGY, 2022, 15 : 179 - 186
  • [36] Respiratory hypersensitivity reactions to NSAIDs in Europe: the global allergy and asthma network (GA2LEN) survey
    Makowska, J. S.
    Burney, P.
    Jarvis, D.
    Keil, T.
    Tomassen, P.
    Bislimovska, J.
    Brozek, G.
    Bachert, C.
    Baelum, J.
    Bindslev-Jensen, C.
    Bousquet, J.
    Bousquet, P. J.
    Kai-Hakon, C.
    Dahlen, S. E.
    Dahlen, B.
    Fokkens, W. J.
    Forsberg, B.
    Gjomarkaj, M.
    Howarth, P.
    Salagean, E.
    Janson, C.
    Kasper, L.
    Kraemer, U.
    Louiro, C.
    Lundback, B.
    Minov, J.
    Nizankowska-Mogilnicka, E.
    Papadopoulos, N.
    Sakellariou, A. G.
    Todo-Bom, A.
    Toskala, E.
    Zejda, J. E.
    Zuberbier, T.
    Kowalski, M. L.
    ALLERGY, 2016, 71 (11) : 1603 - 1611
  • [37] Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen)
    Bousquet, J.
    Khaltaev, N.
    Cruz, A. A.
    Denburg, J.
    Fokkens, W. J.
    Togias, A.
    Zuberbier, T.
    Baena-Cagnani, C. E.
    Canonica, G. W.
    van Weel, C.
    Agache, I.
    Ait-Khaled, N.
    Bachert, C.
    Blaiss, M. S.
    Bonini, S.
    Boulet, L. -P.
    Bousquet, P. -J.
    Camargos, P.
    Carlsen, K. -H.
    Chen, Y.
    Custovic, A.
    Dahl, R.
    Demoly, P.
    Douagui, H.
    Durham, S. R.
    van Wijk, R. Gerth
    Kalayci, O.
    Kaliner, M. A.
    Kim, Y. -Y.
    Kowalski, M. L.
    Kuna, P.
    Le, L. T. T.
    Lemiere, C.
    Li, J.
    Lockey, R. F.
    Mavale-Manuel, S.
    Meltzer, E. O.
    Mohammad, Y.
    Mullol, J.
    Naclerio, R.
    Hehir, R. E. O.
    Ohta, K.
    Ouedraogo, S.
    Palkonen, S.
    Papadopoulos, N.
    Passalacqua, G.
    Pawankar, R.
    Popov, T. A.
    Rabe, K. F.
    Rosado-Pinto, J.
    ALLERGY, 2008, 63 : 8 - +
  • [38] A Summary of the New International EAACI/GA(2)LEN/EDF/WAO Guidelines in Urticaria
    Zuberbier, Torsten
    WORLD ALLERGY ORGANIZATION JOURNAL, 2012, 5 : S1 - S5
  • [39] Quality of life in relation to the traffic indicators NO2 and NOx: Results from the Swedish GA2LEN survey
    Forsberg, Bertil
    Sommar, Johan Nilsson
    Ek, Alexandra
    Dahlen, Sven-Erik
    Middelveld, Roelinde
    Backlund, Anders Bjerg
    Bertilsson, Helen
    Ekerljung, Linda
    Malinovschi, Andrei
    Janson, Christer
    Forsberg, Bertil
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [40] Chronic rhinosinusitis in asthma is a negative predictor of quality of life: results from the Swedish GA2LEN survey
    Ek, A.
    Middelveld, R. J. M.
    Bertilsson, H.
    Bjerg, A.
    Ekerljung, L.
    Malinovschi, A.
    Stjarne, P.
    Larsson, K.
    Dahlen, S. -E.
    Janson, C.
    ALLERGY, 2013, 68 (10) : 1314 - 1321